Eliminating Potential Effects of Other Infections during Selection of Nonhuman Primates for COVID-19 Research
Overview
[키워드] ABSL, animal biosafety level
ACE-2, angiotensin-converting enzyme
ARDS, acute respiratory distress syndrome
CNPRC, California National Primate Research Center
E, Envelope
ESR, Erythrocyte sedimentation rate
HAV, Hepatitis A virus
HBV, hepatitis B virus
HGF hepatocyte growth factor
HTLV, human T-cell lymphotropic virus
IFN, interferon
IL, interleukin
IP, Inducible Protein
M, matrix
MCP, monocyte chemotactic proteins
MCSF, macrophage colony-stimulating factor
MIP, macrophage inflammatory protein
N, nucleocapsid
NSP, Non-structural Proteins
RdRp, RNA-dependent RNA polymerase
S, spike
SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2
SFV, simian foamy virus
SOP, standard operating procedures
SRV/D, simian retrovirus type D
STLV, simian T-lymphotropic virus
TB, Tuberculosis
TGF, Transforming growth factor
TMPRSS2 transmembrane serine protease 2
[DOI] 10.30802/AALAS-CM-21-000086 PMC 바로가기 [Article Type] Overview
[DOI] 10.30802/AALAS-CM-21-000086 PMC 바로가기 [Article Type] Overview